Fine Tuning: Scrutinizing International Researchers

"In strengthening the security of our borders, we must also safeguard the unobstructed entry of more than 31 million persons who enter the United States legally each year as visitors, students and temporary workers and over 500 million that cross the Canadian and Mexican ... and other borders to conduct daily business or visit close family members." — Sen. Ted Kennedy (D-Mass.) Nov. 5 press conference. The Sept. 11 terrorist attacks have disrupted the relationship between the United Stat

Written bySuzanne Brummett
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Now more than ever it is critical for researchers, scientists, and postdoctorates coming to the United States to learn immigration regulations to avoid unknowingly and unwittingly violating the law. Statutes passed during the 1990s can, in some cases, bar some violators from returning to this country for several years.

Non-US researchers, especially those from Muslim countries, can expect INS and State Department officials to carry out even tougher screening procedures at airports, consular posts, and border stations. Foreign scientists also may have to endure background checks that hold up their visa issuance. Some leaders even want to bar any foreign national from working with dangerous biological materials while in the United States.

Is the country closing its borders? Hardly, but the government will continue to scrutinize immigrants in its attempts to fight terrorism. Though the country has suffered no documented instances of terrorist attacks since Sept. 11, lawmakers remain understandably ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies